Veracyte | VCYT - DÍVIDA





DÍVIDA Alterar Data
Agenus USD 35.54M 2.34M 2025-03
Agilent USD 3.35B 55M 2025-09
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 366.28M 13.25M 2025-09
Bruker USD 2.01B 426.8M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Illumina USD 2.58B 22M 2025-09
Intrexon USD 0 13.82M 2024-06
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Laboratory Of America USD 6.53B 16.1M 2025-09
Ligand Pharmaceuticals USD 451M 445.26M 2025-09
Myriad Genetics USD 59.3M 19.7M 2025-03
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Siemens EUR 56.02B 673M 2025-09
Sonic Healthcare AUD 4.8B 282.9M 2024-12
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Veracyte USD 40.45M 10.19M 2025-09
Waters USD 1.49B 52.2M 2025-09